The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
SGLT2 inhibitor lowers serum uric acid through alteration of uric acid transport activity in renal tubule by increased glycosuria
Open accessAbstract
Sodium glucose cotransporter 2 (SGLT2) inhibitors have been reported to lower the serum uric acid (SUA) level. To elucidate the mechanism responsible for this reduction, SUA and the urinary excretion rate of uric acid (UE UA) were analysed after the oral administration of luseogliflozin, a SGLT2 inhibitor, to healthy subjects. After dosing, SUA decreased, and a negative correlation was observed between the SUA level and the UE UA, suggesting that SUA decreased as a result of the increase in the UE UA. The increase in UE UA was correlated with an increase in urinary d‐glucose excretion, but not with the plasma luseogliflozin concentration. Additionally, in vitro transport experiments showed that luseogliflozin had no direct effect on the transporters involved in renal UA reabsorption. To explain that the increase in UE UA is likely due to glycosuria, the study focused on the facilitative glucose transporter 9 isoform 2 (GLUT9ΔN, SLC2A9b), which is expressed at the apical membrane of the kidney tubular cells and transports both UA and d‐glucose. It was observed that the efflux of [14 C]UA in Xenopus oocytes expressing the GLUT9 isoform 2 was trans‐stimulated by 10 m m d‐glucose, a high concentration of glucose that existed under SGLT2 inhibition. On the other hand, the uptake of [14 C]UA by oocytes was cis‐inhibited by 100 m m d‐glucose, a concentration assumed to exist in collecting ducts. In conclusion, it was demonstrated that the UE UA could potentially be increased by luseogliflozin‐induced glycosuria, with alterations of UA transport activity because of urinary glucose. © 2014 The Authors. Biopharmaceutics & Drug Disposition. Published by John Wiley & Sons Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular identification of a renal urate–anion exchanger that regulates blood urate levels
Enomoto, A., Kimura, H., Chairoungdua, A., Shigeta, Y., Jutabha, P., Ho Cha, S., Hosoyamada, M., Takeda, M., Sekine, T., Igarashi, T., et al. (2002) · Nature · doi:10.1038/nature742 · Cited by 1,535
Facchini, F. (1991) · JAMA · doi:10.1001/jama.1991.03470210076036 · Cited by 885
Uric acid transport and disease
So, A., & Thorens, B. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42344 · Cited by 861
Bailey, C. J., Gross, J. L., Pieters, A., Bastien, A., & List, J. F. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60407-2 · Cited by 860
Asymptomatic hyperuricemia. Risks and consequences in the normative aging study
Campion, E. W., Glynn, R. J., & Delabry, L. O. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90441-4 · Cited by 851
Vitart, V., Rudan, I., Hayward, C., Gray, N. K., Floyd, J., Palmer, C. N., Knott, S. A., Kolcic, I., Polasek, O., Graessler, J., et al. (2008) · Nature Genetics · doi:10.1038/ng.106 · Cited by 799
Cefalu, W. T., Leiter, L. A., Yoon, K.-H., Arias, P., Niskanen, L., Xie, J., Balis, D. A., Canovatchel, W., & Meininger, G. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60683-2 · Cited by 724
Kolz, M., Johnson, T., Sanna, S., Teumer, A., Vitart, V., Perola, M., Mangino, M., Albrecht, E., Wallace, C., Farrall, M., et al. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000504 · Cited by 658
Kanai, Y., Lee, W. S., You, G., Brown, D., & Hediger, M. A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci116972 · Cited by 630
Prevalence of the Metabolic Syndrome in Individuals with Hyperuricemia
Choi, H. K., & Ford, E. S. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.06.040 · Cited by 601
Effect of insulin on uric acid excretion in humans
Quinones Galvan, A., Natali, A., Baldi, S., Frascerra, S., Sanna, G., Ciociaro, D., & Ferrannini, E. (1995) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1995.268.1.e1 · Cited by 451
Serum Uric Acid and Cardiovascular Events in Successfully Treated Hypertensive Patients
Alderman, M. H., Cohen, H., Madhavan, S., & Kivlighn, S. (1999) · Hypertension · doi:10.1161/01.hyp.34.1.144 · Cited by 441
Relationship of Uric Acid With Progression of Kidney Disease
Chonchol, M., Shlipak, M. G., Katz, R., Sarnak, M. J., Newman, A. B., Siscovick, D. S., Kestenbaum, B., Carney, J. K., & Fried, L. F. (2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2007.05.013 · Cited by 420
ISEKI, K., OSHIRO, S., TOZAWA, M., ISEKI, C., IKEMIYA, Y., & TAKISHITA, S. (2001) · Hypertension Research · doi:10.1291/hypres.24.691 · Cited by 386
SLC2A9 Is a High-Capacity Urate Transporter in Humans
Caulfield, M. J., Munroe, P. B., O'Neill, D., Witkowska, K., Charchar, F. J., Doblado, M., Evans, S., Eyheramendy, S., Onipinla, A., Howard, P., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050197 · Cited by 378
Anzai, N., Ichida, K., Jutabha, P., Kimura, T., Babu, E., Jin, C. J., Srivastava, S., Kitamura, K., Hisatome, I., Endou, H., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.c800156200 · Cited by 359
Functional Characterization of pH-Sensitive Organic Anion Transporting Polypeptide OATP-B in Human
Nozawa, T., Imai, K., Nezu, J.-I., Tsuji, A., & Tamai, I. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.060194 · Cited by 351
Self-citationThe GLUT9 Gene Is Associated with Serum Uric Acid Levels in Sardinia and Chianti Cohorts
Li, S., Sanna, S., Maschio, A., Busonero, F., Usala, G., Mulas, A., Lai, S., Dei, M., Orrù, M., Albai, G., et al. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030194 · Cited by 310
Ishizaka, N., Ishizaka, Y., Toda, E.-I., Nagai, R., & Yamakado, M. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000161274.87407.26 · Cited by 307
Identification and Characterization of Human Glucose Transporter-like Protein-9 (GLUT9)
Augustin, R., Carayannopoulos, M. O., Dowd, L. O., Phay, J. E., Moley, J. F., & Moley, K. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312226200 · Cited by 285
Human Renal Organic Anion Transporter 4 Operates as an Asymmetric Urate Transporter
Hagos, Y., Stein, D., Ugele, B., Burckhardt, G., & Bahn, A. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006040415 · Cited by 273
Sodium Glucose Cotransporter 2 Inhibitors as a New Treatment for Diabetes Mellitus
Nair, S., & Wilding, J. P. H. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0473 · Cited by 263
Extra-Renal Elimination of Uric Acid via Intestinal Efflux Transporter BCRP/ABCG2
Hosomi, A., Nakanishi, T., Fujita, T., & Tamai, I. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030456 · Cited by 258
Self-citationIdentification of a New Urate and High Affinity Nicotinate Transporter, hOAT10 (SLC22A13)
Bahn, A., Hagos, Y., Reuter, S., Balen, D., Brzica, H., Krick, W., Burckhardt, B. C., Sabolić, I., & Burckhardt, G. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800737200 · Cited by 227
Renal glucose reabsorption inhibitors to treat diabetes
Bailey, C. J. (2011) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.11.011 · Cited by 217
Molecular Characteristics of Na+-coupled Glucose Transporters in Adult and Embryonic Rat Kidney
You, G., Lee, W.-S., Barros, E. J. G., Kanai, Y., Huo, T.-L., Khawaja, S., Wells, R. G., Nigam, S. K., & Hediger, M. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.49.29365 · Cited by 201
Choi, H. K., & Ford, E. S. (2008) · Rheumatology · doi:10.1093/rheumatology/ken066 · Cited by 184
Ferrannini, E., Seman, L., Seewaldt‐Becker, E., Hantel, S., Pinnetti, S., & Woerle, H. J. (2013) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12081 · Cited by 181
Shankar, A., Klein, R., Klein, B. E. K., & Nieto, F. J. (2006) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1002095 · Cited by 178
Kakinuma, H., Oi, T., Hashimoto-Tsuchiya, Y., Arai, M., Kawakita, Y., Fukasawa, Y., Iida, I., Hagima, N., Takeuchi, H., Chino, Y., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901893x · Cited by 159
Self-citationUric acid as an independent risk factor in the treatment of hypertension
Ward, H. J. (1998) · The Lancet · doi:10.1016/s0140-6736(05)60816-1 · Cited by 153
Zoppini, G., Targher, G., Negri, C., Stoico, V., Perrone, F., Muggeo, M., & Bonora, E. (2009) · Diabetes Care · doi:10.2337/dc09-0625 · Cited by 142
URIC ACID AND DIABETES: OBSERVATIONS IN A POPULATION STUDY
Herman, J., & Goldbourt, U. (1982) · The Lancet · doi:10.1016/s0140-6736(82)90324-5 · Cited by 127
Wilding, J. P. H., Ferrannini, E., Fonseca, V. A., Wilpshaar, W., Dhanjal, P., & Houzer, A. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12038 · Cited by 120
Iwanaga, T., Kobayashi, D., Hirayama, M., Maeda, T., & Tamai, I. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.006056 · Cited by 103
Self-citationIwanaga, T., Sato, M., Maeda, T., Ogihara, T., & Tamai, I. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.112755 · Cited by 103
Self-citationc/ebpδ Null Mouse as a Model for the Double Knock-out of slc5a8 and slc5a12 in Kidney
Thangaraju, M., Ananth, S., Martin, P. M., Roon, P., Smith, S. B., Sterneck, E., Prasad, P. D., & Ganapathy, V. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.c600189200 · Cited by 95
Diabetes, prediabetes and uricaemia
Herman, J., Medalie, J. H., & Goldbourt, U. (1976) · Diabetologia · doi:10.1007/bf01221964 · Cited by 80
Yamamoto, K., Uchida, S., Kitano, K., Fukuhara, N., Okumura-Kitajima, L., Gunji, E., Kozakai, A., Tomoike, H., Kojima, N., Asami, J., et al. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01340.x · Cited by 66
Yu, L., Lv, J., Zhou, S., Zhu, L., Hou, P., & Zhang, H. (2010) · Human Genetics · doi:10.1007/s00439-010-0927-z · Cited by 57
Functional cooperation of URAT1 (SLC22A12) and URATv1 (SLC2A9) in renal reabsorption of urate
Nakanishi, T., Ohya, K., Shimada, S., Anzai, N., & Tamai, I. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs574 · Cited by 55
Self-citationFunctional Cooperation of SMCTs and URAT1 for Renal Reabsorption Transport of Urate
Lu, Y., Nakanishi, T., & Tamai, I. (2012) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.dmpk-12-rg-070 · Cited by 39
Self-citationSasaki, T., Seino, Y., Fukatsu, A., Sakai, S., & Samukawa, Y. (2014) · Advances in Therapy · doi:10.1007/s12325-014-0102-3 · Cited by 35
Self-citationEffect of phloridzin on uric acid excretion in man
Skeith, M. D., Healey, L. A., & Cutler, R. E. (1970) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1970.219.4.1080 · Cited by 32
Effects of intraluminal D-glucose and probenecid on urate absorption in the rat proximal tubule
Knight, T. F., Senekjian, H. O., Sansom, S. C., & Weinman, E. J. (1979) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1979.236.6.f526 · Cited by 17
Cited by
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2015) · Diabetes Care · doi:10.2337/dc14-2441 · Cited by 3,066
Mechanisms of Cardiovascular Benefits of Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors
Lopaschuk, G. D., & Verma, S. (2020) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2020.02.004 · Cited by 894
Inzucchi, S. E., Zinman, B., Fitchett, D., Wanner, C., Ferrannini, E., Schumacher, M., Schmoor, C., Ohneberg, K., Johansen, O. E., George, J. T., et al. (2018) · Diabetes Care · doi:10.2337/dc17-1096 · Cited by 740
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2015) · Diabetologia · doi:10.1007/s00125-014-3460-0 · Cited by 694
Vallon, V., & Thomson, S. C. (2017) · Diabetologia · doi:10.1007/s00125-016-4157-3 · Cited by 635
Metadata
- Authors
- Chino, Y., Samukawa, Y., Sakai, S., Nakai, Y., Yamaguchi, J., Nakanishi, T., & Tamai, I.
- Venue
- Biopharmaceutics & Drug Disposition
- Publisher
- Wiley
- Published
- 2014-08-06
- Volume
- 35
- Issue
- 7
- Pages
- 391-404
- ISSN
- 0142-2782 (ISSN-L)
- 1099-081X
- OpenAlex
- W1770274352
- Cited by
- 389
- References
- 45
- FWCI
- 15.18
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.